Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group

MLA

Ken-ichi Sawada, et al. “Long-Term Outcome of Patients with Acquired Primary Idiopathic Pure Red Cell Aplasia Receiving Cyclosporine A. A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.” Haematologica, vol. 92, no. 8, Aug. 2007. EBSCOhost, https://doi.org/10.3324/haematol.11192.

APA

Ken-ichi Sawada, Makoto Hirokawa, Naohito Fujishima, Masanao Teramura, Masami Bessho, Kazuo Dan, Hisashi Tsurumi, Shinji Nakao, Akio Urabe, Mitsuhiro Omine, Keiya Ozawa, & PRCA Collaborative Study Group. (2007). Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica, 92(8). https://doi.org/10.3324/haematol.11192

Chicago

Ken-ichi Sawada, Makoto Hirokawa, Naohito Fujishima, Masanao Teramura, Masami Bessho, Kazuo Dan, Hisashi Tsurumi, et al. 2007. “Long-Term Outcome of Patients with Acquired Primary Idiopathic Pure Red Cell Aplasia Receiving Cyclosporine A. A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.” Haematologica 92 (8). doi:10.3324/haematol.11192.